42337 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 28
00:45 UTC
|
SNPS
Synopsys
|
◎ Target | Siti Panigrahi ★★★☆☆ #1482 | Outperform | $600.00→ $550.00-8.3% |
|
Aug 28
00:45 UTC
|
SNOW
Snowflake
|
◎ Target | Raimo Lenschow ★★★★☆ #779 | Equal Weight | $285.00→ $332.00+16.5% |
|
Aug 28
00:45 UTC
|
SMTC
Semtech
|
◎ Target | Craig Ellis ★☆☆☆☆ #3078 | Outperform | $225.00→ $300.00+33.3% |
|
Aug 28
00:45 UTC
|
SLDB
Solid Biosciences
|
◎ Target | Kristen Kluska ★☆☆☆☆ #3076 | Overweight | $16.00→ $26.00+62.5% |
|
Aug 28
00:45 UTC
|
SJM
J. M. Smucker
|
◎ Target | Robert Moskow ★★★☆☆ #1497 | Hold | $123.00→ $136.00+10.6% |
|
Aug 28
00:45 UTC
|
SJM
J. M. Smucker
|
◎ Target | Alexia Howard not yet tracked | Outperform | $137.00→ $157.00+14.6% |
|
Aug 28
00:45 UTC
|
SJM
J. M. Smucker
|
◎ Target | Andrew Lazar ★★★☆☆ #1341 | Equal Weight | $125.00→ $145.00+16.0% |
|
Aug 28
00:45 UTC
|
SJM
J. M. Smucker
|
◎ Target | Chris Carey not yet tracked | Overweight | $129.00→ $144.00+11.6% |
|
Aug 28
00:45 UTC
|
SEI
Solaris Energy Infrastructure
|
◎ Target | Derek Podhaizer ★☆☆☆☆ #2960 | Overweight | $80.00→ $82.00+2.5% |
|
Aug 28
00:45 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Jay Olson ★☆☆☆☆ #2984 | Outperform | $230.00→ $260.00+13.0% |
|
Aug 28
00:45 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Leonid Timashev ★★★☆☆ #1572 | Outperform | $203.00→ $251.00+23.6% |
|
Aug 28
00:45 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Robert Burns ★☆☆☆☆ #3131 | Buy | $195.00→ $280.00+43.6% |
|
Aug 28
00:45 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Gregory Renza ★★★☆☆ #1201 | Buy | $231.00→ $239.00+3.5% |
|
Aug 28
00:45 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Robert Driscoll ★★☆☆☆ #2656 | Outperform | $201.00→ $225.00+11.9% |
|
Aug 28
00:45 UTC
|
RPC
Ridgepost Capital
|
◎ Target | Chris Kotowski ★★★★★ #167 | Outperform | $16.00→ $15.00-6.2% |
|
Aug 28
00:45 UTC
|
RLJ
RLJ Lodging Trust
|
◎ Target | Richard Hightower ★★★☆☆ #1977 | Underweight | $9.50→ $11.00+15.8% |
|
Aug 28
00:45 UTC
|
RHP
Ryman Hospitality Properties
|
◎ Target | Richard Hightower ★★★☆☆ #1977 | Overweight | $130.00→ $147.00+13.1% |
|
Aug 28
00:45 UTC
|
PUMP
ProPetro
|
◎ Target | Derek Podhaizer ★☆☆☆☆ #2960 | Overweight | $18.00→ $15.00-16.7% |
|
Aug 28
00:45 UTC
|
PK
Park Hotels & Resorts
|
◎ Target | Richard Hightower ★★★☆☆ #1977 | Equal Weight | $12.00→ $14.00+16.7% |
|
Aug 28
00:45 UTC
|
PGR
Progressive
|
◎ Target | Brian Meredith ★★★★☆ #891 | Neutral | $225.00→ $234.00+4.0% |
|
Aug 28
00:45 UTC
|
PEB
Pebblebrook Hotel Trust
|
◎ Target | Richard Hightower ★★★☆☆ #1977 | Underweight | $15.00→ $14.00-6.7% |
|
Aug 28
00:45 UTC
|
P
Everpure
|
◎ Target | Aaron Rakers ★★★☆☆ #1262 | Overweight | $97.00→ $135.00+39.2% |
|
Aug 28
00:45 UTC
|
P
Everpure
|
◎ Target | Asiya Merchant ★★★☆☆ #1024 | Buy | $118.00→ $130.00+10.2% |
|
Aug 28
00:45 UTC
|
P
Everpure
|
◎ Target | David Vogt ★★★☆☆ #1616 | Sell | $70.00→ $80.00+14.3% |
|
Aug 28
00:45 UTC
|
P
Everpure
|
◎ Target | Samik Chatterjee ★★★☆☆ #2104 | Overweight | $130.00→ $145.00+11.5% |
|
Aug 28
00:45 UTC
|
P
Everpure
|
◎ Target | Matt Bryson ★★★☆☆ #2147 | Outperform | $127.00→ $130.00+2.4% |
|
Aug 28
00:45 UTC
|
P
Everpure
|
◎ Target | Mike Cikos ★★★★☆ #896 | Buy | $100.00→ $140.00+40.0% |
|
Aug 28
00:45 UTC
|
P
Everpure
|
◎ Target | Benjamin Swinburne ★★☆☆☆ #2885 | Overweight | $108.00→ $119.00+10.2% |
|
Aug 28
00:45 UTC
|
OWL
Blue Owl Capital
|
◎ Target | Chris Kotowski ★★★★★ #167 | Outperform | $15.00→ $17.00+13.3% |
|
Aug 28
00:45 UTC
|
OOMA
Ooma
|
◎ Target | Josh Nichols ★★★☆☆ #2065 | Buy | $24.00→ $27.00+12.5% |
|
Aug 28
00:45 UTC
|
ONT
Oxford Nanopore Technologies
|
◎ Target | firm only | Overweight | GBX 190→ GBX 220+15.8% |
|
Aug 28
00:45 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Mark Carden ★★★☆☆ #2012 | Neutral | $87.00→ $85.00-2.3% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Kingsley Crane ★★★★☆ #813 | Buy | $115.00→ $175.00+52.2% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Shrenik Kothari ★★★★★ #285 | Outperform | $175.00→ $185.00+5.7% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Rob Owens ★★★★☆ #515 | Neutral | $105.00→ $160.00+52.4% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Roger Boyd ★★★★☆ #347 | Buy | $150.00→ $200.00+33.3% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Peter Weed ★★★★★ #205 | Outperform | $141.00→ $143.00+1.4% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Adam Tindle ★★★★★ #148 | Outperform | $115.00→ $185.00+60.9% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Ittai Kidron ★★★★★ #324 | Outperform | $170.00→ $190.00+11.8% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Rustam Kanga ★★★★☆ #628 | Market Outperform | $170.00→ $180.00+5.9% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Simeon Gutman ★★★☆☆ #1700 | Overweight | $180.00→ $200.00+11.1% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Rudy Kessinger ★★★★☆ #516 | Buy | $165.00→ $190.00+15.2% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Eric Heath ★★★★☆ #675 | Overweight | $180.00→ $190.00+5.6% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Jonathan Ruykhaver ★★★★★ #314 | Overweight | $170.00→ $200.00+17.6% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Gray Powell ★★★★★ #304 | Buy | $167.00→ $187.00+12.0% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Mike Cikos ★★★★☆ #896 | Buy | $140.00→ $200.00+42.9% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Fatima Boolani ★★★★☆ #397 | Neutral | $105.00→ $165.00+57.1% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Brent Thill ★★★☆☆ #1068 | Buy | $170.00→ $200.00+17.6% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Brian Essex ★★★★☆ #811 | Overweight | $165.00→ $190.00+15.2% |
|
Aug 28
00:45 UTC
|
OKTA
Okta
|
◎ Target | Keith Bachman ★★★★☆ #802 | Outperform | $168.00→ $187.00+11.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.